Patrizia Cavazzoni, leader of the FDA's Center for Drug Evaluation and Research, is leaving the agency on Jan. 18.
The director of the FDA's main drug review office will exit on Jan. 18, according to an email sent to staff. Her departure is ...
Hosted on MSN14d
FDA CDER director Patrizia Cavazzoni announces resignationFollowing a string of FDA resignations, Patrizia Cavazzoni has announced that her last day will be 18 January.
FDA's Patrizia Cavazzoni to retire as CDER chief in 2nd senior official's departure in span of weeks
The FDA’s influential director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., will soon retire from the agency. The seven-year FDA veteran communicated the decision in ...
Investor's Business Daily on MSN8d
Here's How Donald Trump Could Shake Up Health Care — And Biotech StocksBiotech stocks have slumped 15% since Donald Trump won his second presidency. That's because Trump comes with a lot of ...
Dr. Scott Manthei of the Nevada Ear and Sinus Institute has been advising patients against taking drugs like Sudafed for ...
and FDA Center for Drug Evaluation and Research director Patrizia Cavazzoni have retired or intend to retire prior to Trump's inauguration on Jan. 20. Becerra, one of those leaving office ...
Patrizia Cavazzoni, leader of the Food and Drug Administration’s Center for Drug Evaluation and Research, is leaving the agency on Jan. 18. The director shared the news with staff on Friday ...
The US Food and Drugs Administration (FDA) has confirmed that its director of the Centre for Drug Evaluation and Research (CDER), Patrizia Cavazzoni, has announced her resignation ahead of Donald ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback